Fluctuating plasma levels of the active moiety of risperidone is related to occurrence of extrapyramidal symptoms

In the present study, we compared the plasma levels of the active moiety (i.e. risperidone plus 9-hydroxyrisperidone) in a steady state in 54 Japanese schizophrenic patients with or without emerging extrapyramidal symptoms (EPS and non-EPS groups, respectively) who were treated with 4 mg/day risperi...

Full description

Saved in:
Bibliographic Details
Published in:International journal of psychiatry in clinical practice 2009-01, Vol.13 (1), p.21-24
Main Authors: Yoshimura, Reiji, Ueda, Nobuhisa, Ikenouch-Sugita, Atsuko, Umene-Nakano, Wakako, Hori, Hikaru, Kakihara, Shingo, Nakamura, Jun
Format: Article
Language:English
Subjects:
9-hydroxyrisperidone
adherence
extrapyramidal symptoms
Risperidone
schizophrenia
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In the present study, we compared the plasma levels of the active moiety (i.e. risperidone plus 9-hydroxyrisperidone) in a steady state in 54 Japanese schizophrenic patients with or without emerging extrapyramidal symptoms (EPS and non-EPS groups, respectively) who were treated with 4 mg/day risperidone. No differences were observed in the plasma levels of the active moiety at 4 and 8 weeks after risperiodne administration in both groups. However, the EPS group patients showed a greater number of fluctuations/larger fluctuations in the plasma active moiety levels than those in the non-EPS group. These results suggest that a stable plasma active moiety level maybe important for preventing EPSs during treatment with risperidone.
ISSN:1365-1501
1471-1788
DOI:10.1080/13651500802331532